Susan McGowan, a nurse from North Lanarkshire, died after taking two doses of the weight-loss drug tirzepatide, with its use noted as a contributing factor.
McGowan's death certificate indicates multiple organ failure, septic shock, and pancreatitis, raising concerns about the safety of prescribed weight-loss drugs.
The manufacturer of Mounjaro emphasized patient safety, stating they are committed to ongoing monitoring and reporting of safety information for all their medicines.
Dr. Alison Cave from MHRA expressed that medicines are only approved when they meet high standards of safety, quality, and effectiveness, underlining regulators' commitment.
Collection
[
|
...
]